{"company":{"id":48175,"name":"Profluent","domain":"profluent.bio","url":"https://alion.io/company/profluent"},"answer":"As of Nov 16, 2026, Alion lists 10 companies most like Profluent: Kytopen, uniQure, Endura, Crisprqc, | Century Therapeutics, AskBio, Agenus Inc., Genprex, Lygenesis and Syncromune.","highlights":["Profluent itself has 12 open roles on Alion.","Of them, uniQure is hiring the most, with 25 open roles.","Syncromune has raised the most venture funding on record: $159M.","Open roles at uniQure rose the most: from 20 on Sep 28, 2026 to 25 now."],"as_of":"2026-11-16","cite":"Alion, \"Profluent competitors and alternatives: 10 similar companies compared on hiring and funding\", as of Nov 16, 2026. https://alion.io/company/profluent/competitors","indexable":true,"target":{"name":"Profluent","url":"https://alion.io/company/profluent","domain":"profluent.bio","open_roles":12,"open_roles_change":null,"funding":{"total_raised_usd":149000000,"last_round":"venture","last_round_usd":106000000,"last_round_date":"2025-11-21","lead_investors":["Spark Capital"]},"size_band":"51-200","headquarters":{"city":"Berkeley","country":"US"},"technologies":["Machine Learning","GCP","PyTorch"],"hiring_countries":["US"],"similarity":null},"competitors":[{"name":"Kytopen","url":"https://alion.io/company/kytopen","domain":"kytopen.com","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":52707234,"last_round":"venture","last_round_usd":7082651,"last_round_date":"2025-02-06","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Cambridge","country":"US"},"technologies":[],"hiring_countries":[],"similarity":{"score":15.5,"shared_segments":["Cell & Gene Therapy","Biotechnology"],"shared_technologies":[],"same_hq_country":true}},{"name":"uniQure","url":"https://alion.io/company/uniqure-com","domain":"uniqure.com","open_roles":25,"open_roles_change":{"since":"2026-09-28","from":20,"to":25,"pct":25},"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"501-1000","headquarters":{"city":"Lexington","country":"US"},"technologies":["Microsoft Excel","Power BI","Microsoft Fabric"],"hiring_countries":["US","CH","NL"],"similarity":{"score":14.82,"shared_segments":["Cell & Gene Therapy","Biotechnology"],"shared_technologies":["Python","SQL","Spark","GCP","Azure"],"same_hq_country":true}},{"name":"Endura","url":"https://alion.io/company/endura-3","domain":"enduratx.com","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"11-50","headquarters":{"city":"South San Francisco","country":"US"},"technologies":[],"hiring_countries":[],"similarity":{"score":14.75,"shared_segments":["Cell & Gene Therapy","Biotechnology"],"shared_technologies":[],"same_hq_country":true}},{"name":"Crisprqc","url":"https://alion.io/company/crisprqc","domain":"crisprqc.com","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":4775632,"last_round":"venture","last_round_usd":3890632,"last_round_date":"2024-01-02","lead_investors":[]},"size_band":"11-50","headquarters":{"city":"San Diego","country":"US"},"technologies":[],"hiring_countries":[],"similarity":{"score":14.75,"shared_segments":["Cell & Gene Therapy","Biotechnology"],"shared_technologies":[],"same_hq_country":true}},{"name":"| Century Therapeutics","url":"https://alion.io/company/centurytx","domain":"centurytx.com","open_roles":2,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":null,"headquarters":{"city":"Branchburg","country":"US"},"technologies":["GLP","GMP","Bioreactors"],"hiring_countries":["US"],"similarity":{"score":14.55,"shared_segments":["Cell & Gene Therapy","Biotechnology"],"shared_technologies":["GCP","Cell Culture"],"same_hq_country":true}},{"name":"AskBio","url":"https://alion.io/company/askbio","domain":"askbio.com","open_roles":4,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":null,"headquarters":{"city":"Durham","country":"US"},"technologies":["GCP","GMP","Chromatography"],"hiring_countries":["US"],"similarity":{"score":14.42,"shared_segments":["Cell & Gene Therapy","Biotechnology"],"shared_technologies":["SQL","GCP","Cell Culture","Next-Generation Sequencing","LIMS"],"same_hq_country":true}},{"name":"Agenus Inc.","url":"https://alion.io/company/agenusbio","domain":"agenusbio.com","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"201-500","headquarters":{"city":"Lexington","country":"US"},"technologies":[],"hiring_countries":[],"similarity":{"score":14.25,"shared_segments":["Cell & Gene Therapy","Biotechnology"],"shared_technologies":[],"same_hq_country":true}},{"name":"Genprex","url":"https://alion.io/company/genprex","domain":"genprex.com","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":10949971,"last_round":"venture","last_round_usd":10000000,"last_round_date":"2018-05-09","lead_investors":[]},"size_band":"11-50","headquarters":{"city":"Austin","country":"US"},"technologies":[],"hiring_countries":[],"similarity":{"score":14.25,"shared_segments":["Cell & Gene Therapy","Biotechnology"],"shared_technologies":[],"same_hq_country":true}},{"name":"Lygenesis","url":"https://alion.io/company/lygenesis","domain":"lygenesis.com","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":25825226,"last_round":"venture","last_round_usd":17764699,"last_round_date":"2023-10-05","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Pittsburgh","country":"US"},"technologies":[],"hiring_countries":[],"similarity":{"score":14.17,"shared_segments":["Cell & Gene Therapy","Biotechnology"],"shared_technologies":[],"same_hq_country":true}},{"name":"Syncromune","url":"https://alion.io/company/syncromune","domain":"syncromune.com","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":159008791,"last_round":"venture","last_round_usd":144828791,"last_round_date":"2024-12-03","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Fort Lauderdale","country":"US"},"technologies":[],"hiring_countries":[],"similarity":{"score":14.17,"shared_segments":["Cell & Gene Therapy","Biotechnology"],"shared_technologies":[],"same_hq_country":true}}],"method":"Ranked by Alion's similar-companies engine (the MCP tool similar_companies): shared industry segments and the overlap of the two segment sets, technologies named in both companies' job postings, the same headquarters country, a size band near it. Open roles are the visible postings on Alion today; their change is shown only for boards that state posting dates.","html_url":"https://alion.io/company/profluent/competitors","json_url":"https://alion.io/company/profluent/competitors.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","built_at":"2026-11-16T03:07:55Z","generated_at":"2026-11-17T23:49:56Z"}}